MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, PRTA had -$40,592K decrease in cash & cash equivalents over the period.

Cash Flow Overview

Change in Cash
-$40,592K

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Cash Flow
2025-09-30
2025-06-30
Net loss
-36,541 -185,962
Depreciation
229 448
Share-based compensation
7,199 23,367
Deferred income taxes
0 43,239
Reduction in the carrying amount of right-of-use assets
714 1,369
Loss on disposal of fixed assets
-1 -2
Accounts receivable
0 0
Prepaid and other assets
-5,295 -3,883
Accounts payable, accruals and other liabilities
-1,632 -7,895
Deferred revenue
-2,415 -7,198
Restructuring liability
-12,716 30,330
Operating lease liabilities
-699 -1,286
Net cash used in operating activities
-40,565 -99,703
Purchases of property and equipment
10 128
Net cash used in investing activities
-10 -128
Proceeds from issuance of ordinary shares in at-the-market offering, net-At The Market Offering
-17 -122
Proceeds from issuance of ordinary shares upon exercise of stock options
0 0
Net cash provided by (used in) financing activities
-17 -122
Net decrease in cash, cash equivalents and restricted cash
-40,592 -99,953
Cash and cash equivalents at beginning of period
472,248 -
Cash and cash equivalents at end of period
331,703 -
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

PROTHENA CORP PUBLIC LTD CO (PRTA)

PROTHENA CORP PUBLIC LTD CO (PRTA)